Status: Recruiting
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
ADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.
Participants needed: 50
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Rohto Pharmaceutical Co., Ltd.Updated: Jun 9, 2026Locations: 1
Eligibility criteria
Patients clinically diagnosed with chronic heart failure due to ischemic heart d... [+2]
Patients who have a combination of cardiovascular disease such as severe organic... [+2]